<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Pathol. Oncol. Res.</journal-id>
<journal-title>Pathology &#x26; Oncology Research</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Pathol. Oncol. Res.</abbrev-journal-title>
<issn pub-type="epub">1532-2807</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1610954</article-id>
<article-id pub-id-type="doi">10.3389/pore.2023.1610954</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pathology and Oncology Archive</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer</article-title>
<alt-title alt-title-type="left-running-head">Rubovszky et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/pore.2023.1610954">10.3389/pore.2023.1610954</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rubovszky</surname>
<given-names>G&#xe1;bor</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1217286/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kocsis</surname>
<given-names>Judit</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bo&#xe9;r</surname>
<given-names>Katalin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chilingirova</surname>
<given-names>Nataliya</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dank</surname>
<given-names>Magdolna</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kah&#xe1;n</surname>
<given-names>Zsuzsanna</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaidarova</surname>
<given-names>Dilyara</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>K&#xf6;v&#xe9;r</surname>
<given-names>Erika</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krakovsk&#xe1;</surname>
<given-names>Bibiana Vert&#xe1;kov&#xe1;</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>M&#xe1;hr</surname>
<given-names>K&#xe1;roly</given-names>
</name>
<xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mri&#x148;&#xe1;kov&#xe1;</surname>
<given-names>Bela</given-names>
</name>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pik&#xf3;</surname>
<given-names>B&#xe9;la</given-names>
</name>
<xref ref-type="aff" rid="aff12">
<sup>12</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bo&#x17e;ovi&#x107;-Spasojevi&#x107;</surname>
<given-names>Ivana</given-names>
</name>
<xref ref-type="aff" rid="aff13">
<sup>13</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horv&#xe1;th</surname>
<given-names>Zsolt</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<on-behalf-of>on behalf of the Central-Eastern European Academy of Oncology (CEEAO) International Professional Panel</on-behalf-of>
<xref ref-type="fn" rid="fn2">
<sup>&#x2021;</sup>
</xref>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Clinical Pharmacology</institution>, <institution>National Institute of Oncology</institution>, <institution>Chest and Abdominal Tumours Chemotherapy &#x201c;B&#x201d;</institution>, <addr-line>Budapest</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Center of Oncoradiology</institution>, <institution>B&#xe1;cs-Kiskun County Teaching Hospital</institution>, <addr-line>Kecskem&#xe9;t</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Oncology</institution>, <institution>Szent Margit Hospital</institution>, <addr-line>Budapest</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Clinic Center of Excellence</institution>, <institution>Heart and Brain Hospital</institution>, <institution>Science and Research Institute</institution>, <institution>Medical University-Pleven</institution>, <addr-line>Pleven</addr-line>, <country>Bulgaria</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Oncology Centre</institution>, <institution>Semmelweis University</institution>, <addr-line>Budapest</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Oncotherapy Clinic</institution>, <institution>University of Szeged</institution>, <addr-line>Szeged</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Kazakh Institute of Oncology and Radiology</institution>, <addr-line>Almaty</addr-line>, <country>Kazakhstan</country>
</aff>
<aff id="aff8">
<sup>8</sup>
<institution>Institute of Oncotherapy</institution>, <institution>Faculty of Medicine</institution>, <institution>University of P&#xe9;cs</institution>, <addr-line>P&#xe9;cs</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff9">
<sup>9</sup>
<institution>1st Department of Oncology</institution>, <institution>Faculty of Medicine</institution>, <institution>Comenius University</institution>, <addr-line>Bratislava</addr-line>, <country>Slovakia</country>
</aff>
<aff id="aff10">
<sup>10</sup>
<institution>Medical Oncology Department</institution>, <institution>St. Elisabeth Cancer Institute</institution>, <addr-line>Bratislava</addr-line>, <country>Slovakia</country>
</aff>
<aff id="aff11">
<sup>11</sup>
<institution>Department of Oncology</institution>, <institution>Szent Rafael Hospital of Zala County</institution>, <addr-line>Zalaegerszeg</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff12">
<sup>12</sup>
<institution>County Oncology Centre</institution>, <institution>P&#xe1;ndy K&#xe1;lm&#xe1;n Hospital of B&#xe9;k&#xe9;s County Council</institution>, <addr-line>Gyula</addr-line>, <country>Hungary</country>
</aff>
<aff id="aff13">
<sup>13</sup>
<institution>Institute for Oncology and Radiology of Serbia</institution>, <institution>Daily Chemotherapy Hospital</institution>, <addr-line>Belgrade</addr-line>, <country>Serbia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/415488/overview">Andrea Lad&#xe1;nyi</ext-link>, National Institute of Oncology (NIO), Hungary</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: G&#xe1;bor Rubovszky, <email>rubovszkyg@gmail.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work and share first authorship</p>
</fn>
<fn fn-type="other" id="fn2">
<label>
<sup>&#x2021;</sup>
</label>
<p>Panel members are listed in the Supplementary Appendix</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>31</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>29</volume>
<elocation-id>1610954</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Rubovszky, Kocsis, Bo&#xe9;r, Chilingirova, Dank, Kah&#xe1;n, Kaidarova, K&#xf6;v&#xe9;r, Krakovsk&#xe1;, M&#xe1;hr, Mri&#x148;&#xe1;kov&#xe1;, Pik&#xf3;, Bo&#x17e;ovi&#x107;-Spasojevi&#x107; and Horv&#xe1;th.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Rubovszky, Kocsis, Bo&#xe9;r, Chilingirova, Dank, Kah&#xe1;n, Kaidarova, K&#xf6;v&#xe9;r, Krakovsk&#xe1;, M&#xe1;hr, Mri&#x148;&#xe1;kov&#xe1;, Pik&#xf3;, Bo&#x17e;ovi&#x107;-Spasojevi&#x107; and Horv&#xe1;th</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Pathol. Oncol. Res." journal-id-type="nlm-ta" xlink:href="10.3389/pore.2022.1610383" ext-link-type="doi">A Corrigendum on <article-title>Systemic treatment of breast cancer. 1st Central-Eastern European professional consensus statement on breast cancer</article-title> by Rubovszky G, Kocsis J, Bo&#xe9;r K, Chilingirova N, Dank M, Kah&#xe1;n Z, Kaidarova D, K&#xf6;v&#xe9;r E, Krakovsk&#xe1; BV, M&#xe1;hr K, Mri&#x148;&#xe1;kov&#xe1; B, Pik&#xf3; B, Bo&#x17e;ovi&#x107;-Spasojevi&#x107; I and Horv&#xe1;th Z (2022). Pathol. Oncol. Res. 28:1610383. doi: <object-id>10.3389/pore.2022.1610383</object-id>
</related-article>
<kwd-group>
<kwd>early breast cancer</kwd>
<kwd>locally advanced breast cancer</kwd>
<kwd>adjuvant treatment</kwd>
<kwd>neoadjuvant treatment</kwd>
<kwd>metastatic breast cancer</kwd>
<kwd>inflammatory breast cancer</kwd>
<kwd>guideline</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>In the original article, the reference for <bold>118</bold> was incorrectly written as:</p>
<p>&#x201c;Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, et al. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer: ALTERNATIVE. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2018;36(8):741-8.&#x201d;</p>
<p>It should be</p>
<p>&#x201c;Johnston SRD, Hegg R, Im SA, Park IH, Burdaeva O, Kurteva G, et al. Phase III, Randomized Study of Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade With Lapatinib Plus Trastuzumab in Combination With an Aromatase Inhibitor in Postmenopausal Women With HER2&#x2010;Positive, Hormone Receptor-Positive Metastatic Breast Cancer: Updated Results of ALTERNATIVE. J Clin Oncol. 2021;39(1):79&#x2013;89. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.20.01894">10.1200/JCO.20.01894</ext-link>.&#x201d;</p>
<p>The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.</p>
</body>
</article>